Cargando…

Anticancer potential of emodin

Traditional Chinese Medicine (TCM) is widely used in clinical research due to its low toxicity, low number of side effects, and low cost. Many components of common fruits and vegetables play well-documented roles as chemopreventive or chemotherapeutic agents that suppress tumorigenesis. Anthraquinon...

Descripción completa

Detalles Bibliográficos
Autores principales: Hsu, Shu-Chun, Chung, Jing-Gung
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Published by Elsevier B.V. 2012
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7104001/
https://www.ncbi.nlm.nih.gov/pubmed/32289000
http://dx.doi.org/10.1016/j.biomed.2012.03.003
_version_ 1783512161136410624
author Hsu, Shu-Chun
Chung, Jing-Gung
author_facet Hsu, Shu-Chun
Chung, Jing-Gung
author_sort Hsu, Shu-Chun
collection PubMed
description Traditional Chinese Medicine (TCM) is widely used in clinical research due to its low toxicity, low number of side effects, and low cost. Many components of common fruits and vegetables play well-documented roles as chemopreventive or chemotherapeutic agents that suppress tumorigenesis. Anthraquinones are commonly extracted from the Polygonaceae family of plants, e.g., Rheum palmatum and Rheum officinale. Some of the major chemical components of anthraquinone and its derivatives, such as aloe-emodin, danthron, emodin, chrysophanol, physcion, and rhein, have demonstrated potential anticancer properties. This review evaluates the pharmacological effects of emodin, a major component of Aloe vera. In particular, emodin demonstrates anti-neoplastic, anti-inflammatory, anti-angiogenesis, and toxicological potential for use in pharmacology, both in vitro and in vivo. Emodin demonstrates cytotoxic effects (e.g., cell death) through the arrest of the cell cycle and the induction of apoptosis in cancer cells. The overall molecular mechanisms of emodin include cell cycle arrest, apoptosis, and the promotion of the expression of hypoxia-inducible factor 1α, glutathione S-transferase P, N-acetyltransferase, and glutathione phase I and II detoxification enzymes while inhibiting angiogenesis, invasion, migration, chemical-induced carcinogen-DNA adduct formation, HER2/neu, CKII kinase, and p34cdc2 kinase in human cancer cells. Hopefully, this summary will provide information regarding the actions of emodin in cancer cells and broaden the application potential of chemotherapy to additional cancer patients in the future.
format Online
Article
Text
id pubmed-7104001
institution National Center for Biotechnology Information
language English
publishDate 2012
publisher Published by Elsevier B.V.
record_format MEDLINE/PubMed
spelling pubmed-71040012020-03-31 Anticancer potential of emodin Hsu, Shu-Chun Chung, Jing-Gung Biomedicine (Taipei) Article Traditional Chinese Medicine (TCM) is widely used in clinical research due to its low toxicity, low number of side effects, and low cost. Many components of common fruits and vegetables play well-documented roles as chemopreventive or chemotherapeutic agents that suppress tumorigenesis. Anthraquinones are commonly extracted from the Polygonaceae family of plants, e.g., Rheum palmatum and Rheum officinale. Some of the major chemical components of anthraquinone and its derivatives, such as aloe-emodin, danthron, emodin, chrysophanol, physcion, and rhein, have demonstrated potential anticancer properties. This review evaluates the pharmacological effects of emodin, a major component of Aloe vera. In particular, emodin demonstrates anti-neoplastic, anti-inflammatory, anti-angiogenesis, and toxicological potential for use in pharmacology, both in vitro and in vivo. Emodin demonstrates cytotoxic effects (e.g., cell death) through the arrest of the cell cycle and the induction of apoptosis in cancer cells. The overall molecular mechanisms of emodin include cell cycle arrest, apoptosis, and the promotion of the expression of hypoxia-inducible factor 1α, glutathione S-transferase P, N-acetyltransferase, and glutathione phase I and II detoxification enzymes while inhibiting angiogenesis, invasion, migration, chemical-induced carcinogen-DNA adduct formation, HER2/neu, CKII kinase, and p34cdc2 kinase in human cancer cells. Hopefully, this summary will provide information regarding the actions of emodin in cancer cells and broaden the application potential of chemotherapy to additional cancer patients in the future. Published by Elsevier B.V. 2012-09 2012-05-11 /pmc/articles/PMC7104001/ /pubmed/32289000 http://dx.doi.org/10.1016/j.biomed.2012.03.003 Text en Copyright © 2012 Published by Elsevier B.V. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Article
Hsu, Shu-Chun
Chung, Jing-Gung
Anticancer potential of emodin
title Anticancer potential of emodin
title_full Anticancer potential of emodin
title_fullStr Anticancer potential of emodin
title_full_unstemmed Anticancer potential of emodin
title_short Anticancer potential of emodin
title_sort anticancer potential of emodin
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7104001/
https://www.ncbi.nlm.nih.gov/pubmed/32289000
http://dx.doi.org/10.1016/j.biomed.2012.03.003
work_keys_str_mv AT hsushuchun anticancerpotentialofemodin
AT chungjinggung anticancerpotentialofemodin